ENVB
NASDAQ
$1.27
Enveric Biosciences Inc (ENVB)
Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer. The company is headquartered in Naples, Florida.
Sector:
Healthcare
Industry:
Biotechnology
Target: $10 (+687.40%)
Market Cap
$4.15M
P/B Ratio
0.86
Price Chart
Valuation
Market Cap$4.15M
Forward P/E23.09
P/S0.08
P/B0.86
Profitability
Gross Profit (TTM)$8.15M
EBITDA-$8.06M
Profit Margin16.6%
Operating Margin13.4%
EPS-$16.54
Growth & Risk
EPS 5Y CAGR-52.22%
FCF 5Y CAGR+10.97%
Sharpe Ratio-0.69